Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06463249 · ClinicalTrials.gov registry record · NA
Behavioral Weight Loss for Cancer Survivors in Maryland: A Trial With Adaptive Interventions
A NA study of Weight Loss, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT06463249: Recruiting NA study of Weight Loss, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
NCT06463249 is a NA study of Weight Loss that is actively recruiting participants, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 200 participants, below the 1,500-participant average among 116 other Weight Loss trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06463249, a NA study of Weight Loss, is actively recruiting participants, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the HELPLINE Weight Loss Program is to determine the comparative effectiveness of two active multi-component, augmented interventions for cancer survivors with overweight or obesity who do not achieve early weight loss goal in the initial intervention period (termed, early non-responders). The core study design is randomized controlled trial with adaptive intervention. 1. CORE Helpline in all participants (first 2 months) 2. Extended Helpline in early responders (additional 6 months) 3. Enhanced Helpline in early non-responders (additional 6 months) 4. Intensive Helpline in early non-responders (additional 6 months)
Primary Outcome
Weight change for Enhanced Helpline and Intensive Helpline in early non-responders
Conditions Studied
Interventions
- BEHAVIORAL CORE Helpline
- BEHAVIORAL Extended Helpline
- BEHAVIORAL Enhanced Helpline
- BEHAVIORAL Intensive Helpline
Study Locations (1)
Maryland
- Johns Hopkins ProHealth - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-06-17 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT06463249 shows while recruiting
NCT06463249 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,500-participant average among 116 other Weight Loss trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Weight Loss appearing as the primary indexed condition, and to 4 interventions - of which CORE Helpline is the first listed.
NCT06463249 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06463249 about?
NCT06463249 is a clinical study titled "Behavioral Weight Loss for Cancer Survivors in Maryland: A Trial With Adaptive Interventions". The objective of the HELPLINE Weight Loss Program is to determine the comparative effectiveness of two active multi-component, augmented interventions for cancer survivors with overweight or obesity who do not achieve early weight loss goal in the initial intervention period (termed, early non-respo...
What is the current status of trial NCT06463249?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-06-17. Estimated completion is 2027-12.
What conditions does trial NCT06463249 study?
This clinical trial studies the following conditions: Weight Loss.
What interventions are being tested in trial NCT06463249?
The interventions under investigation include: CORE Helpline (BEHAVIORAL), Extended Helpline (BEHAVIORAL), Enhanced Helpline (BEHAVIORAL), Intensive Helpline (BEHAVIORAL).
Who is sponsoring clinical trial NCT06463249?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06463249 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Weight Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06463249's enrollment target sits among peer trials
200 28th of 116 higher than 89 of 116 other Weight Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Weight Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Metabolic Health, Bones and Nuts During Weight Loss in Adults
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
Circadian Time Restricted Eating
RECRUITING · NA
-
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI